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Corrigiola telephiifolia Pourr. (Caryophyllaceae) is a Moroccan medicinal plant. Despite its popular usage, no study has been
published concerning its toxicological proﬁle. The acute toxicity of C. telephiifolia root extract was evaluated by giving it orally
to mice at single doses of 5000, 10000, and 14000mg/kg bodyweight. The extract was also administered at doses of 5, 70, and
2000mg/kg bodyweight per day to rats for a forty-day toxicity study. No mortality or signs of toxicity were observed in the acute
study. In the forty-day study in rats, the extract at 5mg/kg/day showed no toxicological eﬀects in either sex. At 70mg/kg/day,
the treated group diﬀered from the control only by a signiﬁcant decrease in serum concentrations of sodium and chloride ions
(P<. 05). At the dose of 2000mg/kg/day, the extract signiﬁcantly increased the serum concentrations of creatinine, alkaline
phosphatase,gamma-glutamyltransferaseandphosphorus(P<. 05)allsuggestiveoffunctionalnephrotoxicityandhepatotoxicity.
The relative bodyweight of both sexes decreased at the dose of 2000mg/kg/day, with a fast recovery for males. Histological
examination did not reveal any treatment-related eﬀects. In conclusion, Corrigiola extract appears safe at the doses used ethno-
medicinally. Much higher doses pose toxicological risks.
1.Introduction
Plants which are commonly used in traditional medicine
are frequently promoted as natural and, therefore, harmless.
This assessment is based on their usage in the treatment
of diseases over centuries [1, 2]. However, some medicinal
plants must be used with caution because they can cause
adverse reactions, especially if they are taken in excessive
doses, or if they interact with conventional drugs [3–
13]. Consequently, in response to public health concerns,
research that focuses on deﬁciencies in the knowledge about
medicinal plants and their potential toxicities is highly
encouraged by many oﬃcial medical and scientiﬁc orga-
nizations [14–17] and by complementary and alternative
medicine (CAM) researchers and practitioners [18, 19].
In Morocco, the use of medicinal plants is an important
and essential part of the culture and of the traditional
healthcare system. However, the production, prescription,
and use of these plants are not currently regulated. As
a result, there is always the danger of inappropriate use,
incorrect identiﬁcation, and interactions with concurrently
administered drugs.
Corrigiola telephiifolia Pourr. (Caryophyllaceae) is a
Moroccan medicinal plant called “Sarghina.” It is a herb,
widely branched from the base, with slender prostrate
branches and tiny compact inﬂorescences. The root, which
is used for medicinal and cosmetic purposes, is a perennial
tap root. This species is found in Southern Europe and
North Africa. In Morocco, it grows in cultivated beds on
rocky and sandy soils. It is widely spread in the Atlas and2 Evidence-Based Complementary and Alternative Medicine
Rif mountains [20]. Morocco exports annually a quantity of
about 370 tons [21]. When burned, the root of this plant
releases an aromatic fume. The root is also used to treat
ﬂu, dermatological diseases, inﬂammation, ulcer, cough, and
jaundice; it is also used as an anasthenic and a diuretic
[20]. Corrigiola root is part of a traditional remedy given
to parturient women. The powdered root is traditionally
consumed plain, mixed with honey, or simply sprinkled on
food ([22], personal investigation).
Despite the exposure of the Moroccan population to this
plant and particularly its use by many women in delicate
health conditions (e.g., postpartum period), there is no
information in the scientiﬁc literature on its toxicity proﬁle,
its chemical composition, or its pharmacological properties,
except for one orphan report on its anti-inﬂammatory
activity [23].
The present investigation was therefore undertaken to
evaluate the potential toxic risks incurred following the
ingestion of hydroalcohol extract of Corrigiola telephiifolia in
rodents.
2. Methods
2.1. Preparation of Corrigiola telephiifolia Extract. Corrigiola
telephiifoliaPourr.(Caryophyllaceae)wascollectedduringits
blossoming stage in June 2003 from Ben Slimane in western
Morocco. The whole plant was identiﬁed by Professor A.
Ouyahya, a taxonomist from the Scientiﬁc National Institute
(Rabat); A voucher specimen (N◦ RAB65892) was deposited
in the Botany Department.
The roots were separated from the aerial parts of the
plant, washed, cut into small pieces, and dried under shade.
They were thereafter ground into a powder. A quantity of
the powder (400g) was exhaustively extracted with ethanol-
water mixture (75:25) in a Soxhlet extractor. The aqueous
ethanol extract was concentrated to dryness under vacuum.
The residue (yield = 33%w/w) was stored in a refrigerator at
4◦C until the time of drug administration.
2.2. Phytochemical Screening. Preliminary phytochemical
screening of the extract involved qualitative determinations
of the following substances: alkaloids, saponins, terpenes,
tannins, quinones, and ﬂavonoids. Determinations were
carried out in accordance with procedures described by
Harborne [24].
2.3. Experimental Animals. Adult Swiss albino mice and
Wistarratsofeithersexwereusedfortheacuteandforty-day
toxicity studies, respectively. The animals were supplied by
the Animal Care Facility of the Faculty of Sciences Semlalia,
Cadi Ayyad University, Marrakech, Morocco. They were
housed in groups of four animals in stainless steel cages
(males separated from females) and kept under standard
environmental conditions (25 ± 2◦C; 12/12h light/dark
cycle).TheywerefedadlibitumwithCicalimpellets(Cicalim
s.a., Casablanca, Morocco) and barley. All animals had free
access to tap water. They were acclimatized for 5 days before
the beginning of the study. All studies were conducted
after obtaining prior approval from the institutional ethical
committee in accordance with the National Institute of
Health “Guide for the Care and Use of Laboratory Animals”
(NIH publication no. 85-23, 1985).
2.4. Acute Toxicity. Before the experiment, the mice did not
have access to food for four hours as recommended by the
Food and Drug Administration [25]. C. telephiifolia extract
was then dissolved in distilled water and given orally to
four groups of mice (n = 16/dose, eight males and eight
females) at single doses of 0, 5000, 10000, and 14000mg/kg
bodyweight. These doses took into account the solubility
of the extract in distilled water. Animals were observed
during the ﬁrst 12 hours for signs and symptoms such as
modiﬁcations in autonomic activity, posture, piloerection,
and respiratory pattern. Other signs and symptoms observed
include occurrence of hemorrhage, diarrhea, convulsions,
tremors, sedation, and death. The mice were weighed daily
and observed for fourteen days following treatment. At the
end of the fourteen-day period, the animals were sacriﬁced
under urethane anesthesia (1g/kg, i.p.). The heart, liver, kid-
neys, pancreas, lungs, stomach, and spleen were immediately
removed, weighed, and placed in Bouin’s solution. After
dehydrating and embedding, sections of 4-5 microns thick
were cut using a rotary microtone. The sections were stained
with haematoxylin and eosin and examined microscopically.
2.5. Forty-Day Toxicity. Sixty-four (64) rats were randomly
assigned into four groups (n = 16), which include eight
males and eight females in each group. Prior to the experi-
ment, the animals were kept away from food overnight [26].
The ﬁrst group served as control (only water given), while
the remaining three groups each received daily doses of 5,
70, and 2000mg/kg body weight of C. telephiifolia extract
p.o. for forty days. After the last dose, rats were not fed
overnight. They were anesthetized (on day 41) by intra-
peritoneal injection of a dose of urethane (1g/kg). Blood
was collected in two types of tubes: one with EDTA and
the other without additives. The anticoagulated blood (tube
with EDTA) was analyzed immediately for hematological
parameters. The second tube was centrifuged at 3000rpm
at 4◦C for 10min to obtain the serum for biochemical
analysis. The animals were then sacriﬁced by exsanguination
under urethane anesthesia and the organs were removed for
histopathological analysis.
2.6. Bodyweight, Mortality, and Clinical Signs. During the
forty-day dosing period, all animals were weighed and
observeddailyforconvulsions,excitement,posture,piloerec-
tion, breathing diﬃculty, sedation, anorexia, diarrhea, hem-
orrhage, and death. Observations were made immediately
before dosing, and up to four hours after dosing.
2.7. Biochemical Analysis. Biochemical analysis of serum
samples was performed using an automatic chemistry ana-
lyzer (Vitros System Chemistry 250, Ortho Clinical Diagnos-
tics,JohnsonandJohnsonCompany,USA).Thebiochemical
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magnesium, calcium, iron, bicarbonate ion, phosphorus,
total protein, glucose, urea, uric acid, and creatinine. Oth-
ers include cholesterol, triglycerides, bilirubin, aspartate-
aminotransferase (AST), alanine-aminotransferase (ALT),
gamma-glutamyltransferase (GGT), and alkaline phos-
phatase (ALP).
2.8. Hematological Analysis. Hematological analysis was per-
formed using an automatic hematological analyzer (ABX
MICROS 60-OT). The hematological parameters measured
were white blood cell count (WBC), red blood cell count
(RBC), platelets (PLT), red cell distribution width (RDW),
hemoglobin (HGB), hematocrit (Hct), mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH),
mean corpuscular hemoglobin concentration (MCHC), red
cell distribution width (RDW), and mean platelet volume
(MPV).
2.9. Autopsy and Microscopic Examination. Macroscopic
examination of vital organs was carried out soon after
sacriﬁce. Diﬀerent organs, namely, the heart, liver, kidneys,
stomach, lungs, and spleen were surgically removed, placed
on absorbent papers for a few minutes, and then weighed
(absolute organ weight in grams). The relative organ weight
(ROW) of each animal was then calculated as follows:
ROW =

Absolute organ weight

g

Bodyweight of rat on sacriﬁce day

g


× 100.
(1)
Tissue biopsies from excised organs were ﬁxed in Bouin’s
solution. Following dehydration and embedding, sections
were cut at 4-5 microns with the rotary microtone, stained
with hematoxylin and eosin, and examined microscopically
to assess any potential toxic eﬀects [27].
2.10. Statistics. Results are expressed as mean ± standard
error of mean (S.E.M). Signiﬁcant diﬀerences between
control and experimental groups were assessed by Student’s
t-test. Diﬀerences were accepted as signiﬁcant at P<. 05.
3. Results
3.1. Acute Toxicity in Mice. The oral administration of a
single dose (5000, 10000, and 14000mg/kg bodyweight) of
C. telephiifolia extract to mice did not cause death within
the fourteen days of the study (Table 1). No signs of toxi-
city or signiﬁcant bodyweight changes were recorded. The
histopathological examination (not presented) of selected
organs showed normal architecture similar to the control
group. These observations reveal that the oral medium lethal
dose value (LD50) of the hydroethanol root extract of C.
telephiifolia is greater than 14000mg/kg bodyweight in mice.
3.2. Forty-Day Toxicity in Rats.
3.2.1. General Observations. Throughout the 40-day feeding
study, there was no mortality recorded in either the control
Table 1: Eﬀect of single oral doses of Corrigiola telephiifolia extract
in mice.
Dose of CT extracta (mg/kg) Sex D/T
b Symptoms
0M 0 / 8 N o n e
F0 / 8 N o n e
5000 M 0/8 None
F0 / 8 N o n e
10000 M 0/8 None
F0 / 8 N o n e
14000 M 0/8 None
F0 / 8 N o n e
aCorrigiola telephiifolia extract was administered as a single oral dose to
groups of mice. All treated mice were carefully examined for any signs of
toxicity during a period of 14 days.
bD/T: dead /treated mice.
Median lethal dose value (DL50) > 14000mg/kg bodyweight.
or treated groups at the administered doses (Table 2). Rats
treated with a dose of 5mg/kg/day behaved normally, apart
from slight abdominal contractions observed during the
ﬁrst week after the extract administration. The clinical signs
observed in rats treated with an extract dose of 70mg/kg/day
weremainlyabdominalcontractions(observedaftergavage),
reduced activity, hunched posture, loss of appetite, and
mild diarrhea. These clinical signs lasted one or two weeks
depending on the sex (females seemed more susceptible than
males) (Table 2).
At the dose of 2000mg/kg/day, animals, especially
females, seemed more aﬀected. Pronounced clinical signs
such as abdominal contractions, inactivity, prostration,
intense diarrhea, and anorexia were observed in all animals.
In addition, respiratory complications were noted in two
rats. These observations were made during the initial three
to four week period. During the exposure period, setting
aside sex and dose (70, and 2000mg/kg bodyweight), signs
of polyuria were noted among the treated animals and their
feces had taken on the yellow color of the plant extract
(Table 2).
3.2.2. Bodyweight. The mean bodyweights of the animals
in the study are presented in Table 3. Weight gain was
common and signiﬁcant in both sexes of the control rats
and those given 5 or 70mg/kg/day. Animals treated with
2000mg/kg/day showed a signiﬁcant weight loss compared
with the control groups. For males, this reduction in weight
was statistically signiﬁcant during the ﬁrst week. These male
rats subsequently recovered their weight, but female rats did
not recover their weight throughout the treatment period.
3.2.3. HematologicalandBiochemicalParameters. Thehema-
tological parameters were not signiﬁcantly diﬀerent between
the treated rats and the control group (Table 4). The values
of the biochemical parameters of female and male rats are
shown in Tables 5 and 6,r e s p e c t i v e l y .
The doses of 5mg/kg/day and 70mg/kg/day did not
cause any signiﬁcant changes in the measured parameters4 Evidence-Based Complementary and Alternative Medicine
Table 2: Eﬀect of a forty-day oral administration of Corrigiola telephiifolia root extract in rats.
Dose of CT
extracta
(mg/kg)
Sex D/T
b Symptoms Duration of symptoms
0 M0 / 8 N o n e —
F0 / 8 N o n e —
5 M 0/8 Slight abdominal contractionsc —
F 0/8 Slight abdominal contractionsc —
70 M 0/8 (i) Abdominal contractionsc —
(ii) Hypoactivity, hunched posture, loss of appetite, mild diarrhea. 1 week
(iii) Polyuria, yellow feces. 5 weeks
F 0/8 (i) Abdominal contractionsc —
(ii) Hypoactivity, hunched posture, loss of appetite, mild diarrhea. 2 weeks
(iii) Polyuria, yellow feces. 5 weeks
2000 M 0/8 (i) Abdominal contractionsc —
(ii) Hypoactivity, hunched posture, loss of appetite, mild diarrhea. 2-3 weeks
(iii) Polyuria, yellow feces 5 weeks
F 0/8 (i) Abdominal contractionsc —
(ii) Marked hypoactivity, hunched posture, loss of appetite, intense diarrhea, 4 weeks
(iii) Respiratory diﬃculties for 2 rats 1 week
(iv) Polyuria, yellow feces 5 weeks
aCorrigiola telephiifolia extract was administered as a reiterated dose to groups of rats for forty days.
bD/T: dead /treated rats.
cThe abdominal contractions were noted only after the oral administration of the extract.
Table 3: Changes in the mean bodyweight of rats after daily oral treatment (40 days) with Corrigiola telephiifolia extract.
Corrigiola telephiifolia (mg/kg bodyweight)
Control 5 70 2000
Females Days
D1 199.4 ± 4.8 200.3 ± 3.8 216.0 ± 3.5 187.1 ± 3.6
D5 205.4 ± 4.9 206.4 ± 4.7 214.0 ± 4.2 175.0 ± 3.0a∗
D10 210.0 ± 4.6 210.9 ± 4.5 218.0 ± 5.2 175.1 ± 3.4a∗
D15 210.0 ± 5.9 210.2 ± 5.3 220.0 ± 5.2 176.7 ± 3.0a∗
D20 216.8 ± 6.1a 217.1 ± 6.0a 227.0 ± 5.6 182.1 ± 3.7∗
D25 220.1 ± 6.6a 221.0 ± 6.5a 228.0 ± 4.0a 185.5 ± 4.1∗
D30 220.3 ± 6.2a 221.5 ± 6.3a 230.5 ± 5.3a 187.7 ± 5.0∗
D35 222.9 ± 4.8a 224.1 ± 4.9a 231.0 ± 4.8a 189.3 ± 4.1∗
D40 221.5 ± 4.9a 223.8 ± 5.0a 229.0 ± 4.6a 190.9 ± 3.3∗
Males Days
D1 242.8 ± 2.9 245.1 ± 2.6 247.4 ± 3.5 250.5 ± 2.4
D5 251.7 ± 3.2 253.6 ± 3.1 246.7 ± 2.8 242.0 ± 2.5a∗
D10 253.2 ± 3.6a 256.5 ± 3.2a 253.7 ± 3.4a 245.6 ± 2.4
D15 255.5 ± 3.9a 259.4 ± 4.0a 264.6 ± 4.1a 249.1 ± 4.1
D20 261.2 ± 4.6a 264.3 ± 5.1a 267.9 ± 5.0a 251.6 ± 6.3
D25 270.7 ± 5.5a 274.6 ± 5.3a 269.3 ± 5.2a 254.3 ± 4.2∗
D30 273.6 ± 6.2a 277.1 ± 5.6a 274.4 ± 5.2a 259.1 ± 3.1a
D35 276.6 ± 7.0a 280.3 ± 6.2a 277.0 ± 6.1a 264.1 ± 3.6a
D40 277.5 ± 6.6a 281.2 ± 6.5a 277.8 ± 6.0a 266.9 ± 3.5a
Values are expressed as mean ± SEM. The diﬀerent superscript letters indicate statistically signiﬁcant diﬀerences (P<. 05) in the Student’s t-test.
∗as compared with the control group; aas compared with the initial weight of rats on the ﬁrst day (D1) of the treatment for each group.Evidence-Based Complementary and Alternative Medicine 5
Table 4: Eﬀect of a forty-day oral administration of Corrigiola telephiifolia extract on hematological parameters of Wistar rats.
Corrigiola telephiifolia (mg/kg/day)
Control 5 70 2000
Females Parameter
WBC (103/mm3)6 . 2 ± 0.6 6.0 ± 0.5 5.9 ± 0.5 5.9 ± 0.9
RBC (106/mm3)6 . 2 ± 0.4 6.2 ± 0.3 6.5 ± 0.4 6.2 ± 0.3
HGB (g/dL) 10.7 ± 0.7 10.8 ± 0.6 11.2 ± 0.6 10.3 ± 0.4
HCT (%) 33.3 ± 2.3 33.5 ± 2.3 35.2 ± 2.3 32.2 ± 1.6
PLT (103/mm3) 143.0 ± 13.5 145.0 ± 15.1 151.7 ± 19.5 146.4 ± 14.2
MCV (μm3) 54.2 ± 1.0 54.2 ± 0.9 54.3 ± 0.6 52.1 ± 0.4
MCH (pg) 17.4 ± 0.3 17.4 ± 0.2 17.3 ± 0.15 16.6 ± 0.3
MCHC (g/dL) 32.1 ± 0.2 32.0 ± 0.3 32.0 ± 0.3 32.0 ± 0.3
RDW (%) 13.2 ± 0.3 13.3 ± 0.3 13.3 ± 0.2 13.7 ± 0.3
MPV (μm3)9 . 1 ± 0.8 9.2 ± 0.5 10.2 ± 0.5 9.3 ± 1.0
Males
WBC (103/mm3)7 . 4 ± 1.5 6.8 ± 0.9 6.4 ± 0.7 6.8 ± 0.9
RBC (106/mm3)6 . 6 ± 0.3 6.5 ± 0.4 6.4 ± 1.0 7.8 ± 0.9
HGB (g/dL) 10.8 ± 0.4 10.7 ± 0.8 10.3 ± 1.5 12.2 ± 1.1
HCT (%) 34.9 ± 1.5 34.5 ± 1.9 32.9 ± 5.4 41.1 ± 4.9
PLT (103/mm3) 158.2 ± 11.3 149.4 ± 13.2 124.8 ± 14.6 136.2 ± 19.2
MCV (μm3) 53.2 ± 0.7 52.3 ± 0.6 51.6 ± 0.8 52.8 ± 0.6
MCH (pg) 16.5 ± 0.2 16.2 ± 0.2 16.2 ± 0.3 15.8 ± 0.4
MCHC (g/dL) 31.0 ± 0.4 31.2 ± 0.5 31.6 ± 0.7 30.1 ± 0.8
RDW (%) 14.0 ± 0.7 13.7 ± 0.4 13.6 ± 0.3 13.8 ± 0.4
MPV (μm3)7 . 0 ± 1.5 7.2 ± 0.5 7.5 ± 0.4 8.1 ± 0.4
C.telephiifoliaextractwasadministereddailyfor40consecutivedaystorats(n = 8).Dataareexpressedasmean ±S.E.M.Therewerenostatisticallysigniﬁcant
diﬀerences between control and treated groups.
exceptforsodiumandchlorideions,whichweresigniﬁcantly
decreased in the rats that received 70mg/kg/day.
At the dose of 2000mg/kg bodyweight, in addition
to a decrease in sodium and chloride ions observed in
both sexes, the treated females showed signiﬁcant increase
in creatinine, phosphorus, ALP, and GGT. Total proteins
decreased signiﬁcantly when compared with those of the
control group (Table 5).
3.2.4. Autopsy and Microscopic Examination. The macro-
scopic observation of the organs did not present any
signiﬁcant morphological or hemorrhagic changes due to
the administration of the extract. There were also no sta-
tistically signiﬁcant diﬀerences in the relative organ weights
(Table 7). Histopathological examination of the diﬀerent
organsdemonstratedthattherewerenopathologicalfeatures
observed in either the control or the treated groups.
3.3. Phytochemical Screening of the Extract. The phytochem-
ical screening of C. telephiifolia extract revealed the presence
of saponins and terpenes. Alkaloids, tannins, quinones, and
ﬂavonoids were not detected.
4. Discussion
C. telephiifolia is traditionally used to treat diﬀerent illnesses
without any reported toxic signs. It is considered safe by
Moroccan folk ([22], personal investigation). The under-
taken acute toxicity study has apparently conﬁrmed this
reputation. The oral LD50 value in mice which is higher than
14000mg/kg falls into class 5 of the globally harmonized
classiﬁed system for chemical substances and mixtures [28].
Since the acute dose study could not provide a guideline
for selecting doses for the chronic low-dose investigation,
and in the absence of other toxicological data that could
have helped to determine the duration of treatment, this
study was designed using the WHO’s recommendations for
herbal medicine testing [17]. A forty-day oral toxicity study
was consequently performed. This duration of the treatment
corresponds in Moroccan culture to the postpartum period
in which the parturient, called “nafssa,” beneﬁts from
intensivefamilycareandothertypesofhealthcare,including
the use of medicinal plants.
The doses of 5 and 70mg/kg/day of the hydroalcohol
extract p.o were also established from the results of the
ethnological survey conducted within a sample of Moroccan
users and herbal practitioners. These doses correspond
respectively, to “a pinch” and “a spoon” of the plant powder
estimated to be consumed as a remedy for an adult woman
weighing 60kg. The doses also take into account the yield
(33%w/w) of C. telephiifolia obtained with 75% ethanol.
Thethirddoseof2000mg/kg/dayofthehydroalcoholextract
corresponds to the highest dose limit recommended by the
OECD [29] to assess subchronic toxicity when there are no
toxicological data available.6 Evidence-Based Complementary and Alternative Medicine
Table 5: Eﬀect of a forty-day oral administration of Corrigiola telephiifolia extract on biochemical parameters of female Wistar rats.
Corrigiola telephiifolia (mg/kg/day)
Control 5 70 2000
Parameter
Nammol/L 149.4 ± 0.7 148.0 ± 0.5 141.6 ± 1.0∗ 136.1 ± 1.7∗
Clmmol/L 117.3 ± 0.5 116.4 ± 0.3 110.1 ± 0.7∗ 106.3 ± 1.1∗
Kmmol/L 8.5 ± 0.5 8.2 ± 0.6 7.8 ± 0.5 9.3 ± 0.9
Mgmmol/L 1.6 ± 0.2 1.5 ± 0.2 1.5 ± 0.1 1.4 ± 0.1
Cammol/L 2.2 ± 0.2 2.1 ± 0.2 2.0 ± 0.1 2.0 ± 0.1
Ironμmol/L 51.6 ± 4.4 52.3 ± 3.7 53.6 ± 2.8 46.7 ± 4.0
Ph.orgmmol/L 3.2 ± 0.2 3.3 ± 0.4 3.8 ± 0.5 4.3 ± 0.4∗
Total Proteing/L 75.4 ± 1.0 74.1 ± 1.2 70.9 ± 2.0 69.1 ± 1.6∗
Glucosemmol/L 8.0 ± 1.0 7.5 ± 0.8 6.7 ± 0.5 6.4 ± 1.0
Ureammol/L 6.6 ± 0.2 6.3 ± 0.5 5.6 ± 0.5 6.0 ± 0.4
Creatinineμmol/L 26.4 ± 5.1 25.7 ± 1.3 22.9 ± 1.2 87.0 ± 15.6∗
Bicarbonatesmm Hg 16.0 ± 1.8 15.4 ± 1.1 14.0 ± 1.5 20.9 ± 2.1
Uric acidμmol/L 194.5 ± 59.7 183.7 ± 35.2 177.3 ± 43.6 175.6 ± 50.1
Total cholesterolmmol/L 1.7 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.4 ± 0.1
Triglyceridesmmol/L 1.8 ± 0.3 1.7 ± 0.2 1.7 ± 0.2 1.3 ± 0.3
Bilirubinμmol/L 25.4 ± 2.5 25.0 ± 2.4 24.4 ± 2.1 27.4 ± 2.9
ASTUI/L 54.5 ± 6.1 55.1 ± 6.0 57.7 ± 6.2 78.5 ± 21.8
ALTUI/L 20.2 ± 1.7 21.3 ± 2.5 27.1 ± 5.0 33.7 ± 8.6
ALPUI/L 121.7 ± 10.8 115.9 ± 7.5 103.0 ± 9.9 202.1 ± 30.0∗
GGTUI/L 1.4 ± 0.1 1.4 ± 0.2 1.5 ± 0.2 1.9 ± 0.2∗
C. telephiifolia extract was administered daily for 40 consecutive days to rats (n = 8). Data are expressed as mean ± S.E.M.
∗Signiﬁcantly diﬀerent from the control (P<. 05).
Table 6: Eﬀect of a forty-day oral administration of Corrigiola telephiifolia extract on biochemical parameters of male Wistar rats
Corrigiola telephiifolia (mg/kg/day)
Control 5 70 2000
Parameter
Nammol/L 140.9 ± 0.6 139.5 ± 0.3 138.3 ± 0.6∗ 135.1 ± 1.3∗
Clmmol/L 111.3 ± 0.6 110.7 ± 0.2 105.0 ± 0.5∗ 103.4 ± 0.4∗
Kmmol/L 8.0 ± 0.3 8.0 ± 0.4 8.0 ± 0.5 7.7 ± 0.4
Mgmmol/L 1.5 ± 0.1 1.6 ± 0.1 1.9 ± 0.1 1.4 ± 0.1
Cammol/L 1.7 ± 0.1 1.7 ± 0.1 1.9 ± 0.1 1.8 ± 0.1
Ironμmol/L 28.9 ± 1.6 28.7 ± 1.5 28.6 ± 2.2 32.7 ± 2.3
Ph.orgmmol/L 4.4 ± 0.4 4.3 ± 0.4 4.1 ± 0.4 4.5 ± 0.5
Total proteing/L 66.4 ± 1.2 66.5 ± 1.0 67.9 ± 1.1 66.6 ± 1.7
Glucosemmol/L 6.6 ± 0.2 6.5 ± 0.3 6.4 ± 0.4 6.9 ± 0.5
Ureammol/L 5.0 ± 0.3 5.1 ± 0.2 5.1 ± 0.2 4.7 ± 0.3
Creatinineμmol/L 23.2 ± 1.7 23.1 ± 0.9 23.0 ± 0.7 26.8 ± 2.0
BicarbonatesmmHg 21.3 ± 0.8 21.5 ± 0.7 22.1 ± 1.0 20.6 ± 1.3
Uric acidμmol/L 271.1 ± 29.2 264.8 ± 24.5 251.4 ± 21.4 200.9 ± 35.8
Total cholesterolmmol/L 1.5 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 1.7 ± 0.1
Triglyceridesmmol/L 1.2 ± 0.1 1.2 ± 0.1 1.1 ± 0.1 1.2 ± 0.2
Bilirubinμmol/L 27.5 ± 1.3 27.8 ± 1.4 28.1 ± 1.5 31.9 ± 2.0
ASTUI/L 77.9 ± 6.9 79.5 ± 7.3 81.9 ± 7.1 114.5 ± 23.5
ALTUI/L 25.0 ± 1.4 24.7 ± 1.5 22.2 ± 1.3 41.3 ± 9.6
ALPUI/L 146.3 ± 23.6 153.6 ± 21.3 164.1 ± 15.8 173.4 ± 28.3
GGTUI/L 1.5 ± 0.2 1.5 ± 0.1 1.4 ± 0.1 2.2 ± 0.4
C. telephiifolia extract was administered daily for 40 consecutive days to rats (n = 8). Data are expressed as mean ± S.E.M.
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Table 7: Eﬀect of a forty-day oral administration of Corrigiola telephiifolia extract on relative organ weights of Wistar rats.
Corrigiola telephiifolia (mg/kg/day)
Control 5 70 2000
Females Organ
Heart 0.31 ± 0.02 0.30 ± 0.03 0.28 ± 0.02 0.31 ± 0.05
Liver 2.20 ± 0.12 2.25 ± 0.10 2.28 ± 0.10 2.35 ± 0.10
Spleen 0.26 ± 0.03 0.25 ± 0.01 0.21 ± 0.01 0.22 ± 0.03
Stomach 0.65 ± 0.10 0.64 ± 0.08 0.63 ± 0.10 0.68 ± 0.09
Right lung 0.29 ± 0.03 0.3 ± 0.04 0.30 ± 0.03 0.39 ± 0.10
Left lung 0.24 ± 0.04 0.23 ± 0.03 0.22 ± 0.02 0.27 ± 0.07
Right kidney 0.31 ± 0.02 0.30 ± 0.02 0.25 ± 0.02 0.29 ± 0.04
Left kidney 0.29 ± 0.01 0.28 ± 0.01 0.26 ± 0.01 0.28 ± 0.04
Males Organ
Heart 0.32 ± 0.01 0.33 ± 0.01 0.35 ± 0.05 0.30 ± 0.01
Liver 2.60 ± 0.12 2.70 ± 0.14 2.79 ± 0.16 2.76 ± 0.18
Spleen 0.23 ±0.01 0.22 ± 0.01 0.21 ± 0.01 0.22 ± 0.01
Stomach 0.63 ± 0.04 0.64 ± 0.04 0.66 ± 0.04 0.73 ± 0.05
Right lung 0.30 ± 0.01 0.30 ± 0.02 0.30 ± 0.03 0.31 ± 0.02
Left lung 0.22 ± 0.01 0.22 ± 0.01 0.20 ± 0.01 0.21 ± 0.02
Right kidney 0.30 ± 0.01 0.29 ± 0.01 0.28 ± 0.02 0.31 ± 0.01
Left kidney 0.28 ± 0.01 0.29 ± 0.01 0.27 ± 0.02 0.30 ± 0.01
C.telephiifoliaextractwasadministereddailyfor40consecutivedaystorats(n = 8).Dataareexpressedasmean ±S.E.M.Therewerenostatisticallysigniﬁcant
diﬀerences in the relative organ weights.
Nonspeciﬁc clinical signs such as abdominal contrac-
tions, reduced activity and hunched posture were observed
at a dose of 70mg/kg bodyweight. These are probably
behavioral responses to the malaise induced by the extract
[29]. Mild diarrhea was noticed only during the ﬁrst week of
the exposure period, perhaps due to subsequent adaptation.
Intestinal smooth muscle contractions may account for
the observed diarrhea and the abdominal contractions.
Although the smooth muscle contractions have not been
characterized, they may lend credence to the use of the plant
in postpartum hemorrhage.
Changes in serum sodium and chloride concentrations
tend, according to the OECD guideline [29], to occur in
parallel when they are associated with relative water content,
and both electrolytes become depleted by ﬂuid loss. Thus,
the decrease in these two parameters might be related to the
diarrhea observed during the test.
Male rats given 2000mg/kg/day of the extract showed
similar hematological and biochemical responses to those
treated with 70mg/kg/day of the extract. Histopathology
was also similar. In contrast, the female groups were more
sensitive and presented, in addition to decrease in Na
and Cl levels, signs of nephrotoxicity, mild hepatic injury,
and nutrient deﬁciency. These symptoms were revealed by
characteristic biochemical markers such as the increase in
the serum creatinine level and the phosphorus concentration
for kidney injury, the increase in ALP and GGT levels for
liver damage, and the decrease in serum proteins for nutrient
deﬁciency [29–32].
Indeed, the serum protein concentration may decrease
followingaprolongeddeﬁcitinfoodconsumption,areduced
protein synthesis or as a consequence of an elevated protein
loss through renal dysfunction or hemorrhage [29]. In
this study, the protein loss may be justiﬁed by all of
these parameters, except hemorrhage. These parameters are
supported by the observed clinical signs such as frequent
diarrhea and bodyweight loss.
Alkaline phosphatase (ALP) is present in all tissues, but
is particularly concentrated in liver, bile duct, kidney, bone,
and the placenta. The increase in ALP could have been
due to liver injury [27] rather than to other pathological
reasons (bone disease, malignancies, etc.) because of the
corresponding increased activity of GGT [29, 30, 32]. In fact,
serum GGT activity is an eﬀective indicator of hepatobiliary
toxicity in rats [27, 32], and is more speciﬁc than ALP.
ALP can be elevated as a result of toxic eﬀects on bone
formation while serum GGT activity is unaﬀected [29].
ALT is a highly sensitive biomarker of hepatotoxicity [32–
39]. Although not statistically signiﬁcant, the increase in
serum ALT level may support the suggested hepatotoxic-
ity.
Creatinine is formed by nonenzymatic breakdown of
creatine, and changes in its serum concentration are the
result of alterations in renal blood ﬂow, renal function,
or urine outﬂow [29, 48]. The obtained elevated blood
creatinine level, which is a reliable indicator of impaired
glomerular ﬁltration in addition to the rise in serum
phosphate concentration, is a sign of signiﬁcant impairment
of renal function [30]. The fact that a signiﬁcant change in
serum creatinine was observed means that a kidney injury
had already developed following the oral administration of
the high dose of C. telephiifolia [49].8 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Hypothetical diagram of Corrigiola telephiifolia toxicity mechanism through its saponins component. The major symptoms are
nephrotoxicity, hepatic injury, and nutrient deﬁciency. -: inhibition;  : increase;  : decrease; ?: theoretical pattern on the basis of reported
activities of some saponins [40–47]; ns: no statistically signiﬁcant.
All of these ﬁndings (nephrotoxicity, hepatic injury, and
nutrient deﬁciency), observed at the dose of 2000mg/kg/day
in female rats, were not corroborated by histopathological
damages, leading to the conclusion that the toxicological
impact of C. telephiifolia, at this stage, is most likely func-
tionalinnature,ratherthanstructural[50].Thisassumption
does not exclude the fact that in case of chronic or repeated
intermittentuseoftheplant,moreapparentdeleterioussigns
may occur.
The reasons for the diﬀerences in the toxicity pattern
of C. telephiifolia between male and female rats are not
immediatelyknown.Theymayinvolvefactorswhichaccount
for sex-related pharmacokinetic diﬀerences, that is, organ
size, a higher percentage of body fat, and a lower glomerular
ﬁltrationrateinfemalesthanmales[51].Ofotherfactors,sex
diﬀerences of drug-metabolizing enzymes (e.g., cytochrome
P450)and/ortransporterproteins(e.g.,P-glycoprotein)have
been considered important factors [51–57].
The phytochemical screening of the root extract showed
that the plant is rich in terpenes and saponins. Saponins are
known for their wide range of biological activities [58–61].
These activities include disruption of biological membranes
[61] and generation of free radicals [62] that cause lipid
peroxidation[63].Saponinsmakethelipidbilayerpermeable
to macromolecules [64] by inducing pore-like structures
[61]. The subsequent increase of membrane ﬂuidity was
supposed to be one of the key steps in saponin-induced
toxicity [61]. The alteration of the lipid environment around
membrane proteins leads to the alteration of their activities
as transporters, ion channels, and receptors [40–47, 60].
Consequently, changes in some biochemical parameters
levels in both sides of the membrane (electrolytes, enzyme
substrates, enzymes.) may emerge as signs of saponin-
induced biological eﬀects. This may give hypothetical expla-
nations concerning data observed in this study (Figure 1),
bearing in mind that saponins are not the only components
of Corrigiola extract.
In conclusion, C. telephiifolia root extract appears safe at
the doses used ethnomedicinally. Much higher doses pose
toxicological risks. Therefore, it is prudent to undertakeEvidence-Based Complementary and Alternative Medicine 9
additional research in order to characterize other toxicolog-
ical eﬀects which might arise following long-term use of the
extract.
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